129 related articles for article (PubMed ID: 3523271)
21. Short-term tranexamic acid treatment in aneurysmal subarachnoid hemorrhage.
Wijdicks EF; Hasan D; Lindsay KW; Brouwers PJ; Hatfield R; Murray GD; van Gijn J; Vermeulen M
Stroke; 1989 Dec; 20(12):1674-9. PubMed ID: 2595729
[TBL] [Abstract][Full Text] [Related]
22. [Prognosis after ruptured intracranial aneurysm in men and women].
Rosenørn J; Eskesen VN; Schmidt K
Ugeskr Laeger; 1994 Aug; 156(33):4707-9. PubMed ID: 7992404
[TBL] [Abstract][Full Text] [Related]
23. [Treatment of vasospasm in aneurysmal meningeal hemorrhage using intravenous nimodipine. Multicenter cooperative study].
Frerebeau P; Janny P; Taquoi G; Besson G; Buchheit F; Childs M; Houtteville JP; Jan M; Jomin M; Pecker J
Neurochirurgie; 1988; 34(6):383-8. PubMed ID: 3070420
[TBL] [Abstract][Full Text] [Related]
24. Preoperative management of patients with aneurysmal subarachnoid hemorrhage.
Tovi D
J Neurosurg Sci; 1975; 19(1-2):59-64. PubMed ID: 1221096
[No Abstract] [Full Text] [Related]
25. Antifibrinolytic therapy in subarachnoid hemorrhage caused by ruptured intracranial aneurysm.
Ramirez-Lassepas M
Neurology; 1981 Mar; 31(3):316-22. PubMed ID: 7010208
[TBL] [Abstract][Full Text] [Related]
26. [Comparison of 2 consecutive series of aneurysmal subarachnoid hemorrhage with or without nimodipine and study of the temperature curve].
Rousseaux P; Gomis P; Bazin A; Peruzzi P; Scherpereel B; Bernard MH; Bertault R; Graftieaux JP
Neurochirurgie; 1993; 39(3):157-65. PubMed ID: 8295647
[TBL] [Abstract][Full Text] [Related]
27. Prolonged antifibrinolysis: an effective non-surgical treatment for ruptured intracranial aneurysms?
Maurice-Williams RS
Br Med J; 1978 Apr; 1(6118):945-7. PubMed ID: 346153
[TBL] [Abstract][Full Text] [Related]
28. Antifibrinolytic treatment in subarachnoid hemorrhage.
Vermeulen M; Lindsay KW; Murray GD; Cheah F; Hijdra A; Muizelaar JP; Schannong M; Teasdale GM; van Crevel H; van Gijn J
N Engl J Med; 1984 Aug; 311(7):432-7. PubMed ID: 6379455
[TBL] [Abstract][Full Text] [Related]
29. Preoperative prognostic factors for rebleeding and survival in aneurysm patients receiving antifibrinolytic therapy: report of the Cooperative Aneurysm Study.
Torner JC; Kassell NF; Wallace RB; Adams HP
Neurosurgery; 1981 Nov; 9(5):506-13. PubMed ID: 7322311
[TBL] [Abstract][Full Text] [Related]
30. Effect of tranexamic acid on rebleeding after subarachnoid hemorrhage: a double-blind controlled clinical trial.
van Rossum J; Wintzen AR; Endtz LJ; Schoen JH; de Jonge H
Ann Neurol; 1977 Sep; 2(3):238-42. PubMed ID: 365072
[TBL] [Abstract][Full Text] [Related]
31. Antifibrinolytic therapy in ruptured intracranial aneurysm through repeated monitoring of fibrinolytic activity of blood.
Watanabe H; Ito M; Chigasaki H; Ishii S
Neurol Med Chir (Tokyo); 1976; 16(PT1):91-6. PubMed ID: 66644
[No Abstract] [Full Text] [Related]
32. Antifibrinolytic therapy in patients with aneurysmal subarachnoid hemorrhage. A report of the cooperative aneurysm study.
Adams HP; Nibbelink DW; Torner JC; Sahs AL
Arch Neurol; 1981 Jan; 38(1):25-9. PubMed ID: 7458720
[TBL] [Abstract][Full Text] [Related]
33. [Prognosis of subarachnoid hemorrhage from a ruptured cerebral aneurysm in relation to the timing of the intervention].
Innocente F; Tiberio I; Manfio A; Padoan A; Ori C
Minerva Anestesiol; 1993 Nov; 59(11):689-91. PubMed ID: 8170618
[No Abstract] [Full Text] [Related]
34. Saccular aneurysms, subarachnoid hemorrhage, and the timing of surgery.
Kim LY; Tew JM
Heart Lung; 1985 Jan; 14(1):68-74. PubMed ID: 3881369
[No Abstract] [Full Text] [Related]
35. Timing of aneurysm surgery in subarachnoid haemorrhage--an observational study in The Netherlands.
Nieuwkamp DJ; de Gans K; Algra A; Albrecht KW; Boomstra S; Brouwers PJ; Groen RJ; Metzemaekers JD; Nijssen PC; Roos YB; Tulleken CA; Vandertop WP; van Gijn J; Vos PE; Rinkel GJ
Acta Neurochir (Wien); 2005 Aug; 147(8):815-21. PubMed ID: 15944811
[TBL] [Abstract][Full Text] [Related]
36. Prevention of recurrence of spontaneous subarachnoid haemorrhage by tranexamic acid.
Gelmers HJ
Acta Neurochir (Wien); 1980; 52(1-2):45-50. PubMed ID: 7376944
[TBL] [Abstract][Full Text] [Related]
37. Management of poor-grade patients with aneurysmal subarachnoid hemorrhage in the acute stage: Importance of close monitoring for neurological grade changes.
Sasaki T; Sato M; Oinuma M; Sakuma J; Suzuki K; Matsumoto M; Kodama N
Surg Neurol; 2004 Dec; 62(6):531-5; discussion 535-7. PubMed ID: 15576122
[TBL] [Abstract][Full Text] [Related]
38. [Treatment of intracranial aneurysms. Critical review in the light of our 25-year experience].
Quaglietta P; Cerillo A; Vizioli L; Villano M; Bucciero A; Rossi F; Castellano AE; Tedeschi G
Minerva Chir; 1988 Dec; 43(23-24):2081-90. PubMed ID: 3247044
[No Abstract] [Full Text] [Related]
39. [A retrospective analysis of the outcomes of patients with aneurysmal subarachnoid hemorrhages: a focus on the prognostic factors].
Yoshikai S; Nagata S; Ohara S; Yuhi F; Sakata S; Matsuno H
No Shinkei Geka; 1996 Aug; 24(8):733-8. PubMed ID: 8741408
[TBL] [Abstract][Full Text] [Related]
40. Factors associated with aneurysm size in patients with subarachnoid hemorrhage: effect of smoking and aneurysm location.
Qureshi AI; Sung GY; Suri MF; Straw RN; Guterman LR; Hopkins LN
Neurosurgery; 2000 Jan; 46(1):44-50. PubMed ID: 10626934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
